by Miami Stem Cell | Dec 10, 2021 | regenerative medicine, stem cell therapy
AgeX Therapeutics’ Licensee ImStem Biotechnology Does First U.S. Multiple Sclerosis Patient with...
by Miami Stem Cell | Dec 2, 2021 | knee pain, regenerative medicine, stem cell knee injections, stem cell therapy, stem cells for pain management
Stem cell therapy for knees has the potential to provide relief to a lot of people. Knee pain is an common condition that affects millions of Americans and people around the world. Considering the daily load that legs bear, a problem with your knees can limit...
![Case Report: Bell’s Palsy and Stem Cell Therapy]()
by Miami Stem Cell | Nov 29, 2021 | regenerative medicine, stem cell therapy
Abstract Bell’s palsy is the most common form of idiopathic facial paralysis that we see as physicians. We report on a 43-year-old woman with a two-year history of unilateral facial palsy that had stabilized, and was unresponsive to treatment with steroids and...
![Case Report: Bell’s Palsy and Stem Cell Therapy]()
by Miami Stem Cell | Nov 22, 2021 | Arthritis, Celulas Madre, knee pain, regenerative medicine, stem cell knee injections, stem cell therapy
Study design: Systematic literature review. Objective: This study provided a systematic review of randomized controlled trials which assessed the therapeutic effects of stem cell treatments, surgical interventions, and nonsurgical treatments on the outcomes of...
![Case Report: Bell’s Palsy and Stem Cell Therapy]()
by Miami Stem Cell | Nov 8, 2021 | Arthritis, regenerative medicine, stem cell knee injections, stem cell therapy, stem cells for pain management
Stem cells are important for living organisms for many reasons. In the 3- to 5-day-old embryo, called a blastocyst, the inner cells give rise to the entire body of the organism, including all of the many specialized cell types and organs such as the heart, lung, skin,...
![Case Report: Bell’s Palsy and Stem Cell Therapy]()
by Miami Stem Cell | Nov 3, 2021 | regenerative medicine, stem cell therapy
Promising early results show that longstanding Harvard Stem Cell Institute (HSCI) research may have paved the way for a breakthrough treatment of Type 1 diabetes. Utilizing research from the Melton Lab, Vertex Pharmaceuticals has developed VX-880, an investigational...
